Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Mol Cell Proteomics ; 23(5): 100747, 2024 May.
Article in English | MEDLINE | ID: mdl-38490531

ABSTRACT

Although immune tolerance evolved to reduce reactivity with self, it creates a gap in the adaptive immune response against microbes that decorate themselves in self-like antigens. This is particularly apparent with carbohydrate-based blood group antigens, wherein microbes can envelope themselves in blood group structures similar to human cells. In this study, we demonstrate that the innate immune lectin, galectin-4 (Gal-4), exhibits strain-specific binding and killing behavior towards microbes that display blood group-like antigens. Examination of binding preferences using a combination of microarrays populated with ABO(H) glycans and a variety of microbial strains, including those that express blood group-like antigens, demonstrated that Gal-4 binds mammalian and microbial antigens that have features of blood group and mammalian-like structures. Although Gal-4 was thought to exist as a monomer that achieves functional bivalency through its two linked carbohydrate recognition domains, our data demonstrate that Gal-4 forms dimers and that differences in the intrinsic ability of each domain to dimerize likely influences binding affinity. While each Gal-4 domain exhibited blood group-binding activity, the C-terminal domain (Gal-4C) exhibited dimeric properties, while the N-terminal domain (Gal-4N) failed to similarly display dimeric activity. Gal-4C not only exhibited the ability to dimerize but also possessed higher affinity toward ABO(H) blood group antigens and microbes expressing glycans with blood group-like features. Furthermore, when compared to Gal-4N, Gal-4C exhibited more potent antimicrobial activity. Even in the context of the full-length protein, where Gal-4N is functionally bivalent by virtue of Gal-4C dimerization, Gal-4C continued to display higher antimicrobial activity. These results demonstrate that Gal-4 exists as a dimer and exhibits its antimicrobial activity primarily through its C-terminal domain. In doing so, these data provide important insight into key features of Gal-4 responsible for its innate immune activity against molecular mimicry.


Subject(s)
Galectin 4 , Humans , Galectin 4/metabolism , Protein Domains , Protein Binding , Protein Multimerization , Blood Group Antigens/metabolism , Escherichia coli/metabolism , Anti-Infective Agents/pharmacology , ABO Blood-Group System/metabolism , ABO Blood-Group System/immunology
2.
Clin Ophthalmol ; 17: 3249-3259, 2023.
Article in English | MEDLINE | ID: mdl-37927574

ABSTRACT

Purpose: The COVID-19 pandemic affected medical practice worldwide due to interventions to prevent spreading. Its effect on ophthalmology practices in Latin America has not yet been explored. We aimed to assess the perceptions about the pandemic from countries' ophthalmological national and subspecialty retina societies affiliated to the Pan-American Association of Ophthalmology (PAAO). Patients and Methods: A survey-based study of leaders of national ophthalmological and retinal societies was conducted. The survey was sent by email to 30 societies, from which 20 responded (12 countries, 66.6% response rate). It included closed- and open-ended questions about (1) operational capacity and precautions, (2) telemedicine and virtual care, (3) procedures, and (4) post-pandemic considerations. Results: There was a marked decline in ophthalmology patient visits (80-95%) and elective surgeries (90%) during 2020 compared to before the pandemic. Precautions like temperature checks, mask usage, and social distancing were widely implemented while personal protective equipment (PPE) availability varied. Telemedicine use was limited due to lack of experience with it. Reopening plans focused on maintaining precautions and gradually resuming activities. Economic and security concerns were raised, and adherence to guidelines was emphasized. Respondents acknowledged the need to adapt to a "new normal". Long duration drugs, fewer imaging studies, and shorter wait times were preferred; however, availability of long duration drugs was limited. Conclusion: The pandemic impacted ophthalmology in Latin America, with reduced patient visits, procedures, and surgeries. Delayed treatment and complications were likely the result of the pandemic.

3.
Aust J Gen Pract ; 52(9): 643-649, 2023 09.
Article in English | MEDLINE | ID: mdl-37666787

ABSTRACT

BACKGROUND AND OBJECTIVES: This study examined the uptake of influenza vaccine (Vaxigrip Tetra, Sanofi-Aventis) among local patients with type 2 diabetes (T2D) and their intention to receive future flu vaccines. We also explored associations between factors pertinent to the Health Belief Model (HBM) and vaccination behaviour. Based on these findings, targeted strategies to improve flu vaccine uptake are proposed. METHOD: In all, 499 patients with diabetes were recruited from a government general outpatient clinic (GOPC) in Hong Kong between 1 and 14 March 2021. A cross-sectional, questionnaire-based study to investigate vaccination behaviours and the HBM was conducted. A self-reported questionnaire that included sociodemographic data of participants' and patients' knowledge and perceptions related to flu vaccines based on the HBM framework was used. Study subjects aged <18 years and those who were unable to provide consent or had contraindications to flu vaccine were excluded from the study. RESULTS: Among the study sample, the reported flu vaccine uptake rate was 42% during 2020. Results from multivariate logistic analyses revealed a positive correlation between the likelihood of vaccination and factors pertinent to the HBM, such as knowledge that flu vaccine is required annually, not considering side effects from flu vaccine uptake and having better access to flu vaccine. DISCUSSION: The rate of flu vaccine uptake in our study population was suboptimal. Given the significance of influenza among patients with T2D, various public health interventions should be used to promote annual flu vaccine uptake.


Subject(s)
Diabetes Mellitus, Type 2 , Influenza Vaccines , Humans , Adult , Influenza Vaccines/adverse effects , Hong Kong , Cross-Sectional Studies , Ambulatory Care Facilities
4.
Cell Host Microbe ; 31(5): 751-765.e11, 2023 05 10.
Article in English | MEDLINE | ID: mdl-37098341

ABSTRACT

Treating and preventing infections by antimicrobial-resistant bacterial pathogens is a worldwide problem. Pathogens such as Staphylococcus aureus produce an array of virulence determinants, making it difficult to identify single targets for the development of vaccines or monoclonal therapies. We described a human-derived anti-S. aureus monoclonal antibody (mAb)-centyrin fusion protein ("mAbtyrin") that simultaneously targets multiple bacterial adhesins, resists proteolysis by bacterial protease GluV8, avoids Fc engagement by S. aureus IgG-binding proteins SpA and Sbi, and neutralizes pore-forming leukocidins via fusion with anti-toxin centyrins, while maintaining Fc- and complement-mediated functions. Compared with the parental mAb, mAbtyrin protected human phagocytes and boosted phagocyte-mediated killing. The mAbtyrin also reduced pathology, reduced bacterial burden, and protected from different types of infections in preclinical animal models. Finally, mAbtyrin synergized with vancomycin, enhancing pathogen clearance in an animal model of bacteremia. Altogether, these data establish the potential of multivalent mAbs for treating and preventing S. aureus diseases.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Animals , Humans , Staphylococcus aureus , Staphylococcal Infections/drug therapy , Staphylococcal Infections/prevention & control , Staphylococcal Infections/microbiology , Antibodies, Monoclonal/therapeutic use , Phagocytes/metabolism , Leukocidins/metabolism , Leukocidins/therapeutic use
5.
J Infect Dis ; 225(8): 1460-1470, 2022 04 19.
Article in English | MEDLINE | ID: mdl-33895843

ABSTRACT

Vaccines against Staphylococcus aureus have eluded researchers for >3 decades while the burden of staphylococcal diseases has increased. Early vaccine attempts mainly used rodents to characterize preclinical efficacy, and all subsequently failed in human clinical efficacy trials. More recently, leukocidin AB (LukAB) has gained interest as a vaccine antigen. We developed a minipig deep surgical wound infection model offering 3 independent efficacy readouts: bacterial load at the superficial and at the deep-seated surgical site, and dissemination of bacteria. Due to similarities with humans, minipigs are an attractive option to study novel vaccine candidates. With this model, we characterized the efficacy of a LukAB toxoid as vaccine candidate. Compared to control animals, a 3-log reduction of bacteria at the deep-seated surgical site was observed in LukAB-treated minipigs and dissemination of bacteria was dramatically reduced. Therefore, LukAB toxoids may be a useful addition to S. aureus vaccines and warrant further study.


Subject(s)
Staphylococcal Infections , Staphylococcal Vaccines , Animals , Bacterial Load , Bacterial Proteins , Leukocidins , Staphylococcal Infections/microbiology , Staphylococcus aureus , Surgical Wound Infection/prevention & control , Swine , Swine, Miniature , Vaccination
6.
Nat Microbiol ; 6(6): 731-745, 2021 06.
Article in English | MEDLINE | ID: mdl-33875847

ABSTRACT

Staphylococcus aureus has evolved into diverse lineages, known as clonal complexes (CCs), which exhibit differences in the coding sequences of core virulence factors. Whether these alterations affect functionality is poorly understood. Here, we studied the highly polymorphic pore-forming toxin LukAB. We discovered that the LukAB toxin variants produced by S. aureus CC30 and CC45 kill human phagocytes regardless of whether CD11b, the previously established LukAB receptor, is present, and instead target the human hydrogen voltage-gated channel 1 (HVCN1). Biochemical studies identified the domain within human HVCN1 that drives LukAB species specificity, enabling the generation of humanized HVCN1 mice with enhanced susceptibility to CC30 LukAB and to bloodstream infection caused by CC30 S. aureus strains. Together, this work advances our understanding of an important S. aureus toxin and underscores the importance of considering genetic variation in characterizing virulence factors and understanding the tug of war between pathogens and the host.


Subject(s)
Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Ion Channels/metabolism , Leukocidins/genetics , Leukocidins/metabolism , Staphylococcal Infections/metabolism , Staphylococcus aureus/metabolism , Animals , CD11b Antigen/genetics , CD11b Antigen/metabolism , Genetic Variation , Humans , Ion Channels/genetics , Mice, Inbred C57BL , Phagocytes/metabolism , Phagocytes/microbiology , Staphylococcal Infections/genetics , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics
7.
Infect Immun ; 88(10)2020 09 18.
Article in English | MEDLINE | ID: mdl-32719153

ABSTRACT

Bacterial biofilms are linked with chronic infections and have properties distinct from those of planktonic, single-celled bacteria. The virulence mechanisms associated with Staphylococcus aureus biofilms are becoming better understood. Human neutrophils are critical for the innate immune response to S. aureus infection. Here, we describe two virulence strategies that converge to promote the ability of S. aureus biofilms to evade killing by neutrophils. Specifically, we show that while neutrophils exposed to S. aureus biofilms produce extracellular traps (NETs) and phagocytose bacteria, both mechanisms are inefficient in clearance of the biofilm biomass. This is attributed to the leukocidin LukAB, which promotes S. aureus survival during phagocytosis. We also show that the persistence of biofilm bacteria trapped in NETs is facilitated by S. aureus nuclease (Nuc)-mediated degradation of NET DNA. This study describes key aspects of the interaction between primary human neutrophils and S. aureus biofilms and provides insight into how S. aureus evades the neutrophil response to cause persistent infections.


Subject(s)
Bacterial Proteins/immunology , Biofilms , Immune Evasion , Leukocidins/immunology , Micrococcal Nuclease/immunology , Neutrophils/immunology , Staphylococcus aureus/pathogenicity , Bacterial Proteins/genetics , Biofilms/growth & development , Extracellular Traps/immunology , Extracellular Traps/metabolism , Extracellular Traps/microbiology , Humans , Leukocidins/genetics , Microbial Viability , Micrococcal Nuclease/genetics , Neutrophils/microbiology , Neutrophils/pathology , Phagocytosis , Staphylococcus aureus/immunology , Virulence
8.
J Exp Med ; 217(9)2020 09 07.
Article in English | MEDLINE | ID: mdl-32602902

ABSTRACT

Staphylococcus aureus is responsible for various diseases in humans, and recurrent infections are commonly observed. S. aureus produces an array of bicomponent pore-forming toxins that target and kill leukocytes, known collectively as the leukocidins. The contribution of these leukocidins to impair the development of anti-S. aureus adaptive immunity and facilitate reinfection is unclear. Using a murine model of recurrent bacteremia, we demonstrate that infection with a leukocidin mutant results in increased levels of anti-S. aureus antibodies compared with mice infected with the WT parental strain, indicating that leukocidins negatively impact the generation of anti-S. aureus antibodies in vivo. We hypothesized that neutralizing leukocidin-mediated immune subversion by vaccination may shift this host-pathogen interaction in favor of the host. Leukocidin-immunized mice produce potent leukocidin-neutralizing antibodies and robust Th1 and Th17 responses, which collectively protect against bloodstream infections. Altogether, these results demonstrate that blocking leukocidin-mediated immune evasion can promote host protection against S. aureus bloodstream infection.


Subject(s)
Bacteremia/immunology , Bacteremia/prevention & control , Immune Evasion , Leukocidins/metabolism , Staphylococcal Infections/immunology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/immunology , Animals , Antibodies, Neutralizing/immunology , Antibody Formation/immunology , Bacteremia/blood , Bacteremia/microbiology , CD4-Positive T-Lymphocytes/immunology , Cytokines/blood , Host-Pathogen Interactions/immunology , Immunity , Immunization , Immunoglobulin G/blood , Inflammation/pathology , Methicillin-Resistant Staphylococcus aureus/immunology , Mice , Models, Biological , Organ Specificity , Recurrence , Spleen/pathology , Staphylococcal Infections/blood , Toxoids/immunology
9.
Proc Natl Acad Sci U S A ; 116(27): 13563-13572, 2019 07 02.
Article in English | MEDLINE | ID: mdl-31217288

ABSTRACT

The pathogen Staphylococcus aureus colonizes and infects a variety of different sites within the human body. To adapt to these different environments, S. aureus relies on a complex and finely tuned regulatory network. While some of these networks have been well-elucidated, the functions of more than 50% of the transcriptional regulators in S. aureus remain unexplored. Here, we assess the contribution of the LacI family of metabolic regulators to staphylococcal virulence. We found that inactivating the purine biosynthesis regulator purR resulted in a strain that was acutely virulent in bloodstream infection models in mice and in ex vivo models using primary human neutrophils. Remarkably, these enhanced pathogenic traits are independent of purine biosynthesis, as the purR mutant was still highly virulent in the presence of mutations that disrupt PurR's canonical role. Through the use of transcriptomics coupled with proteomics, we revealed that a number of virulence factors are differentially regulated in the absence of purR Indeed, we demonstrate that PurR directly binds to the promoters of genes encoding virulence factors and to master regulators of virulence. These results guided us into further ex vivo and in vivo studies, where we discovered that S. aureus toxins drive the death of human phagocytes and mice, whereas the surface adhesin FnbA contributes to the increased bacterial burden observed in the purR mutant. Thus, S. aureus repurposes a metabolic regulator to directly control the expression of virulence factors, and by doing so, tempers its pathogenesis.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Purines/biosynthesis , Repressor Proteins/metabolism , Staphylococcus aureus/metabolism , Virulence Factors/metabolism , Animals , Bacterial Proteins/physiology , Gene Expression Regulation, Bacterial/physiology , Humans , Mice , Repressor Proteins/physiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/pathogenicity , Transcription Factors/metabolism , Transcription Factors/physiology , Virulence Factors/physiology
10.
Health Educ Behav ; 46(4): 677-688, 2019 08.
Article in English | MEDLINE | ID: mdl-30829066

ABSTRACT

Background. Despite the strong link between health literacy and cardiovascular health outcomes, health literacy measurements remain flawed and fragmented. There exists a gap in the knowledge when formulating a valid measurement to capture the broad concept of health literacy. The existence of various tools for health literacy measurement also hampers the availability of health literacy data. Additionally, little research is available on a valid measurement tool for cardiovascular health literacy. Objective. This study aims to provide an overview of the health literacy measurement tools used in the context of cardiovascular health. Method. A scoping review was conducted. Two electronic databases, Medline and Embase, were searched to identify studies that described a tool for the measurement of health literacy in the context of cardiovascular health. Results. After reviewing the available studies, 53 studies met the inclusion criteria. A total of 26 health literacy measurement tools were identified in the studies. Among the 26 tools, 16 used an objective measurement approach, 9 adopted a subjective approach, and 1 employed a mixed approach. Additionally, 28 studies used tools to measure print literacy, 15 studies measured print literacy and numeracy, and 5 studies measured print literacy, oral literacy, and numeracy. Conclusions. STOFHLA, TOFHLA, and REALM were the mostly commonly used tools in the selected studies. The majority of tools were based heavily on reading skills and word recognition. Researchers should focus on the development of more comprehensive and reliable health literacy measurement tool(s) specific to cardiovascular health to assist health care providers to more efficiently and accurately identify people with cardiovascular problems who have inadequate health literacy.


Subject(s)
Cardiovascular Diseases/psychology , Educational Measurement/methods , Health Literacy , Cardiovascular Diseases/therapy , Health Literacy/methods , Health Literacy/standards , Humans
11.
Cell Host Microbe ; 25(3): 463-470.e9, 2019 Mar 13.
Article in English | MEDLINE | ID: mdl-30799265

ABSTRACT

The pathogenesis of Staphylococcus aureus is thought to depend on the production of pore-forming leukocidins that kill leukocytes and lyse erythrocytes. Two leukocidins, Leukocidin ED (LukED) and γ-Hemolysin AB (HlgAB), are necessary and sufficient to kill mice upon infection and toxin challenge. We demonstrate that LukED and HlgAB cause vascular congestion and derangements in vascular fluid distribution that rapidly cause death in mice. The Duffy antigen receptor for chemokines (DARC) on endothelial cells, rather than leukocytes or erythrocytes, is the critical target for lethality. Consistent with this, LukED and HlgAB injure primary human endothelial cells in a DARC-dependent manner, and mice with DARC-deficient endothelial cells are resistant to toxin-mediated lethality. During bloodstream infection in mice, DARC targeting by S. aureus causes increased tissue damage, organ dysfunction, and host death. The potential for S. aureus leukocidins to manipulate vascular integrity highlights the importance of these virulence factors.


Subject(s)
Bacterial Proteins/toxicity , Bacterial Toxins/toxicity , Duffy Blood-Group System/metabolism , Endothelial Cells/drug effects , Exotoxins/toxicity , Hemolysin Proteins/toxicity , Receptors, Cell Surface/metabolism , Staphylococcal Infections/pathology , Staphylococcus aureus/pathogenicity , Animals , Bacterial Proteins/metabolism , Bacterial Toxins/metabolism , Cell Survival/drug effects , Cells, Cultured , Disease Models, Animal , Exotoxins/metabolism , Hemolysin Proteins/metabolism , Humans , Mice , Mice, Knockout , Models, Biological , Staphylococcus aureus/metabolism , Survival Analysis
12.
Sci Transl Med ; 11(475)2019 01 16.
Article in English | MEDLINE | ID: mdl-30651319

ABSTRACT

A key aspect underlying the severity of infections caused by Staphylococcus aureus is the abundance of virulence factors that the pathogen uses to thwart critical components of the human immune response. One such mechanism involves the destruction of host immune cells by cytolytic toxins secreted by S. aureus, including five bicomponent leukocidins: PVL, HlgAB, HlgCB, LukED, and LukAB. Purified leukocidins can lyse immune cells ex vivo, and systemic injections of purified LukED or HlgAB can acutely kill mice. Here, we describe the generation and characterization of centyrins that bind S. aureus leukocidins with high affinity and protect primary human immune cells from toxin-mediated cytolysis. Centyrins are small protein scaffolds derived from the fibronectin type III-binding domain of the human protein tenascin-C. Although centyrins are potent in tissue culture assays, their short serum half-lives limit their efficacies in vivo. By extending the serum half-lives of centyrins through their fusion to an albumin-binding consensus domain, we demonstrate the in vivo efficacy of these biologics in a murine intoxication model and in models of both prophylactic and therapeutic treatment of live S. aureus systemic infections. These biologics that target S. aureus virulence factors have potential for treating and preventing serious staphylococcal infections.


Subject(s)
Biological Factors/pharmacology , Leukocidins/metabolism , Neutralization Tests , Staphylococcus aureus/metabolism , Amino Acid Sequence , Animals , Cytoprotection/drug effects , Cytotoxicity, Immunologic , Hemolysis/drug effects , Humans , Leukocidins/chemistry , Mice , Neutrophils/drug effects , Neutrophils/metabolism , Phagocytes/drug effects , Staphylococcal Infections/microbiology , Staphylococcal Infections/pathology , Staphylococcus aureus/drug effects
13.
Proc Natl Acad Sci U S A ; 115(28): 7416-7421, 2018 07 10.
Article in English | MEDLINE | ID: mdl-29941565

ABSTRACT

Bacterial biofilms efficiently evade immune defenses, greatly complicating the prognosis of chronic infections. How methicillin-resistant Staphylococcus aureus (MRSA) biofilms evade host immune defenses is largely unknown. This study describes some of the major mechanisms required for S. aureus biofilms to evade the innate immune response and provides evidence of key virulence factors required for survival and persistence of bacteria during chronic infections. Neutrophils are the most abundant white blood cells in circulation, playing crucial roles in the control and elimination of bacterial pathogens. Specifically, here we show that, unlike single-celled populations, S. aureus biofilms rapidly skew neutrophils toward neutrophil extracellular trap (NET) formation through the combined activity of leukocidins Panton-Valentine leukocidin and γ-hemolysin AB. By eliciting this response, S. aureus was able to persist, as the antimicrobial activity of released NETs was ineffective at clearing biofilm bacteria. Indeed, these studies suggest that NETs could inadvertently potentiate biofilm infections. Last, chronic infection in a porcine burn wound model clearly demonstrated that leukocidins are required for "NETosis" and facilitate bacterial survival in vivo.


Subject(s)
Bacterial Proteins/immunology , Biofilms , Extracellular Traps/immunology , Immune Evasion , Leukocidins/immunology , Neutrophils/immunology , Staphylococcal Skin Infections/immunology , Staphylococcus aureus/physiology , Wound Infection/immunology , Animals , Extracellular Traps/microbiology , Humans , Staphylococcal Skin Infections/pathology , Swine , Wound Infection/microbiology , Wound Infection/pathology
14.
J Bacteriol ; 199(24)2017 12 15.
Article in English | MEDLINE | ID: mdl-28924032

ABSTRACT

Staphylococcus aureus is a major human pathogen that imposes a great burden on the health care system. In the development of antistaphylococcal modalities intended to reduce the burden of staphylococcal disease, it is imperative to select appropriate models of S. aureus strains when assessing the efficacy of novel agents. Here, using whole-genome sequencing, we reveal that the commonly used strain Newman D2C from the American Type Culture Collection (ATCC) contains mutations that render the strain essentially avirulent. Importantly, Newman D2C is often inaccurately referred to as simply "Newman" in many publications, leading investigators to believe it is the well-described pathogenic strain Newman. This study reveals that Newman D2C carries a stop mutation in the open reading frame of the virulence gene regulator, agrA In addition, Newman D2C carries a single-nucleotide polymorphism (SNP) in the global virulence regulator gene saeR that results in loss of protein function. This loss of function is highlighted by complementation studies, where the saeR allele from Newman D2C is incapable of restoring functionality to an saeR-null mutant. Additional functional assessment was achieved through the use of biochemical assays for protein secretion, ex vivo intoxications of human immune cells, and in vivo infections. Altogether, our study highlights the importance of judiciously screening for genetic changes in model S. aureus strains when assessing pathogenesis or the efficacy of novel agents. Moreover, we have identified a novel SNP in the virulence regulator gene saeR that directly affects the ability of the protein product to activate S. aureus virulence pathways.IMPORTANCEStaphylococcus aureus is a human pathogen that imposes an enormous burden on health care systems worldwide. This bacterium is capable of evoking a multitude of disease states that can range from self-limiting skin infections to life-threatening bacteremia. To combat these infections, numerous investigations are under way to develop therapeutics capable of thwarting the deadly effects of the bacterium. To generate successful treatments, it is of paramount importance that investigators use suitable models for examining the efficacy of the drugs under study. Here, we demonstrate that a strain of S. aureus commonly used for drug efficacy studies is severely mutated and displays markedly reduced pathogenicity. As such, the organism is an inappropriate model for disease studies.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial/physiology , Staphylococcus aureus/genetics , Staphylococcus aureus/pathogenicity , Bacterial Proteins/genetics , Genome, Bacterial , Mutation , Polymorphism, Single Nucleotide , Staphylococcus aureus/classification , Transcription Factors/genetics , Transcription Factors/metabolism , Virulence , Whole Genome Sequencing
16.
Int J Pediatr Otorhinolaryngol ; 76(10): 1485-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22796196

ABSTRACT

OBJECTIVE: Exploratory research findings have suggested that otoacoustic emission (OAE) recordings may be predictive for infants at risk of sudden infant death syndrome (SIDS). The present study aimed to investigate whether an actual SIDS prevalence rate was comparable to OAE-determined rates for "at risk" status. METHODS: Previously collected OAE results from 521 infants in Hong Kong were used for analyses and OAE-determined "at risk" rate compared to the prevalence rate for SIDS in Hong Kong infants. RESULTS: Results indicated that the OAE-determined rates were very much greater than the actual prevalence of SIDS in Hong Kong. CONCLUSION: The use of OAE screening to identify infants at risk for SIDS is therefore not advisable, using present criteria, as false alarm rates would be very high and this may cause unnecessary parental anxiety and a considerable additional burden to the health care system.


Subject(s)
Otoacoustic Emissions, Spontaneous , Sudden Infant Death/epidemiology , Analysis of Variance , Female , Humans , Infant, Newborn , Male , Prevalence , Risk Assessment , Signal-To-Noise Ratio
17.
Article in English | MEDLINE | ID: mdl-19363614

ABSTRACT

In some species, females develop bright colouration to signal reproductive status and exhibit behavioural repertoires to incite male courtship and/or reduce male harassment and forced copulation. Sex steroids, including progesterone and testosterone, potentially mediate female reproductive colouration and reproductive behaviour. We measured associations among plasma profiles of testosterone and progesterone with variation in colour expression and reproductive behaviour, including unique courtship rejection behaviours, in female Lake Eyre dragon lizards, (Ctenophorus maculosus). At onset of breeding, progesterone and testosterone increased with vitellogenesis, coincident with colour intensification and sexual receptivity, indicated by acceptance of copulations. As steroid levels peaked around the inferred ovulation time, maximal colour development occurred and sexual receptivity declined. When females were gravid and exhibited maximal mate rejection behaviours, progesterone levels remained consistently high, while testosterone exhibited a discrete second peak. At oviposition, significant declines in plasma steroid levels, fading of colouration and a dramatic decrease in male rejection behaviours co-occurred. Our results indicate a generally concordant association among steroid levels, colouration, behaviour and reproductive events. However, the prolonged elevation in progesterone and a second peak of testosterone was unrelated to reproductive state or further colour change, possibly suggesting selection on females to retain high steroid levels for inducing rejection behaviours.


Subject(s)
Lizards/physiology , Mating Preference, Animal , Progesterone/blood , Reproduction/physiology , Sex Characteristics , Skin Pigmentation/physiology , Testosterone/blood , Animals , Courtship , Female , Male , Ovulation/physiology , Progesterone/physiology , Testosterone/physiology , Vitellogenesis/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...